Literature DB >> 8236009

Parathyroid carcinoma: diagnosis and clinical history.

J T Vetto1, M F Brennan, J Woodruf, M Burt.   

Abstract

BACKGROUND: Parathyroid carcinoma is often over-diagnosed based on histologic appearance alone. We limited the definition of the disease to patients with recurrence, metastases, or frank capsular invasion on histologic examination.
METHODS: With these criteria, fourteen cases of parathyroid carcinoma seen at our institution from 1955 to the present were identified.
RESULTS: All patients presented with hypercalcemia, and all deaths were due to hypercalcemia. Two patients have been free of disease after initial operation for 31 and 180 months. Six other patients had a prolonged course with a median survival more than 80 months. Two of these patients have undergone one reexcision each for local recurrence, and four have undergone multiple resections for local recurrence or metastases. These reoperations usually resulted in satisfactory, albeit temporary, control of hypercalcemia. Finally, six patients died of disease after an aggressive course, with a short median survival (47 months). Four of these patients were seen in the 1950s before an aggressive approach to metastatic disease was adopted.
CONCLUSIONS: The types of clinical courses observed in this study may be more reflective of the varied biologic features of parathyroid carcinoma and the approach to recurrence than of the initial operations. For patients with recurrent or distant disease, an operation appears to prolong survival and palliate the symptoms of hypercalcemia.

Entities:  

Mesh:

Year:  1993        PMID: 8236009

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  9 in total

1.  Lymph node involvement and surgical approach in parathyroid cancer.

Authors:  Klaus-Martin Schulte; Nadia Talat; John Miell; Caje Moniz; Prakash Sinha; Salvador Diaz-Cano
Journal:  World J Surg       Date:  2010-11       Impact factor: 3.352

Review 2.  Parathyroid carcinoma: case report.

Authors:  G Sturniolo; E Gagliano; A Tonante; F Taranto; E Papalia; R Cascio; C Damiano; F Vermiglio; G Sturniolo
Journal:  G Chir       Date:  2013 May-Jun

3.  Results of iterative surgery for persistent and recurrent parathyroid carcinoma.

Authors:  Maurizio Iacobone; Cesare Ruffolo; Franco Lumachi; Gennaro Favia
Journal:  Langenbecks Arch Surg       Date:  2005-06-03       Impact factor: 3.445

4.  Mortality factors in recurrent parathyroid cancer: a pooled analysis.

Authors:  Wen-Hsuan Tsai; Yi-Hong Zeng; Chun-Chuan Lee; Ming-Chieh Tsai
Journal:  J Bone Miner Metab       Date:  2022-02-20       Impact factor: 2.626

Review 5.  Parathyroid carcinoma: current understanding and new insights into gene expression and intraoperative parathyroid hormone kinetics.

Authors:  Mohamed Abdelgadir Adam; Brian R Untch; John A Olson
Journal:  Oncologist       Date:  2010-01-05

6.  Lung metastasis from parathyroid carcinoma causing recurrent renal hyperparathyroidism in a hemodialysis patient: report of a case.

Authors:  Y Tominaga; M Numano; K Uchida; K Sato; H Asano; T Haba; A Katayama; A Mukoyama; K Suzuki; Y Tanaka
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

7.  Parathyroid Neoplasms: The Army Hospital (Research & Referral) Experience.

Authors:  B Fanthome; R Bharadwaj; K M Suryanarayana
Journal:  Med J Armed Forces India       Date:  2011-07-21

8.  Huge parathyroid carcinoma: clinical considerations and literature review.

Authors:  Maria Grazia Chiofalo; Francesco Scognamiglio; Simona Losito; Secondo Lastoria; Ugo Marone; Luciano Pezzullo
Journal:  World J Surg Oncol       Date:  2005-06-23       Impact factor: 2.754

9.  Management and Outcome of Parathyroid Carcinoma-Induced Primary Hyperparathyroidism: A Single-Centre Experience.

Authors:  Loredana De Pasquale; Antonio Mario Bulfamante; Giovanni Felisati; Luca Castellani; Giorgio Ghilardi; Alberto Maria Saibene
Journal:  Int J Endocrinol       Date:  2021-10-07       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.